Cerebrospinal fluid (CSF) pharmacokinetics of intraventricular vancomycin in patients with staphylococcal ventriculitis associated with external CSF drainage

Clinical Infectious Diseases

Volumn 25, Issue 3, 1997, Pages 733-735

  Pfausler, Bettina ^a,b   Haring, H P ^a   Kampfl, A ^a   Wissel, J ^a   Schober, Maria ^a   Schmutzhard, E ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; VANCOMYCIN;

ARTICLE; BACTERIAL INFECTION; BRAIN VENTRICULITIS; CASE REPORT; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID DRAINAGE; CEREBROSPINAL FLUID LEVEL; DRUG EFFICACY; DRUG SAFETY; HUMAN; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRIORITY JOURNAL; STAPHYLOCOCCUS INFECTION;

EID: 0030752729     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/513756     Document Type: Article

References (10)

1. Bayston R, Hart CA, Barnicoat M. Intraventricular vancomycin in the treatment of ventriculitis associated with cerebrospinal fluid shunting and drainage. J Neurol Neurosurg Psychiatr 1987;50:1419-23.
2. McLaurin RL, Frame PT. Treatment of infections of cerebrospinal fluid shunts. Rev Infect Dis 1987;9:595-603.
3. Cooper GC, Given DB. Vancomycin, a comprehensive review of 30 years of clinical experience. New York: Park Row Publishers, 1986.
4. Arroyo JC, Quindlen EA. Accumulation of vancomycin after intraventricular infusions. South Med J 1983;76:1554-5.
5. Reesor C, Chow AW, Kureishi A, Jewesson PJ. Kinetics of intraventricular vancomycin in infections of cerebrospinal fluid shunts [letter]. J Infect Dis 1988;158:1142-3.
6. Seufert RJ, Blackman P, Hudson W. Recommended procedures for the preparation of intrathecal dosing in the hospital pharmacy. Hosp Pharm 1990;25:849-51.
7. Schwenzer KS, Chao-Huei JW, Anhalt JP. Automated fluorescence polarization immunoassay for monitoring vancomycin. Ther Drug Monit 1983;5:341-5.
8. National Committee for Clinical Laboratory Standards. User evaluation of precision performance of clinical chemistry devices. Vol. 4, no. 8. Villanova, Pennsylvania: National Committee for Clinical Laboratory Standards, 1984.
9. Gump DW. Vancomycin for treatment of bacterial meningitis. Rev Infect Dis 1981;3(suppl):S289-92.
10. Fekety R. Vancomycin and teicoplanin. In: Mandell GL, Douglas RG Jr, Bennett JE, eds. Principles and practice of infectious diseases. 3rd ed. New York: Churchill Livingstone, 1990:317-23.